Overt and occult hepatitis B virus infection in adult Sudanese HIV patients

International Journal of Infectious Diseases

Volumn 29, Issue , 2014, Pages e65-e70

  Mudawi, Hatim ^a   Hussein, Waleed ^b   Mukhtar, Maowia ^b   Yousif, Mukhlid ^c   Nemeri, Omer ^d   Glebe, Dieter ^e   Kramvis, Anna ^c  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF BAHRI   (Sudan)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

HBsAg negative; HBV detection; Hepatitis C virus; Occult HBV infection; PCR

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA; HEPATITIS B ANTIBODY;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EVIDENCE BASED PRACTICE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OCCULT HEPATITIS B VIRUS INFECTION; OVERT HEPATITIS B VIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; SUDANESE; VIRUS LOAD; BLOOD; COINFECTION; COMPLICATION; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREVALENCE; VIREMIA; VIROLOGY;

ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; VIRAL LOAD; VIREMIA;

EID: 84909587842     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.07.004     Document Type: Article

References (42)

1. UNAIDS. Report on the global AIDS epidemic. UNAIDS; 2012. Available at: (accessed July 2013). http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf.
2. World Health Organization. Hepatitis B. Fact sheet No. 204. WHO; 2013. Available at: (accessed July 2013). http://www.who.int/mediacentre/factsheets/fs204/en/.
3. World Health Organization. Hepatitis C. Fact sheet No. 164. WHO; 2013. Available at: (accessed July 2013). http://www.who.int/mediacentre/factsheets/fs164/en/.
4. Lewden C., Salmon D., Morlat P., Bévilacqua S., Jougla E., Bonnet F., et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005, 34:121-130.
5. Thio C.L. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009, 49:S138-S145.
6. Graham C., Baden L., Yu E., Mrus J., Carnie J., Heeren T., et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001, 33:562-569.
7. Mudawi H.M., Smith H.M., Rahoud S.A., Fletcher I.A., Saeed O.K., Fedail S.S. Prevalence of hepatitis B virus infection in the Gezira state of central Sudan. Saudi J Gastroenterol 2007, 13:81-83.
8. McCarthy M.C., Hyams K.C., el-Tigani el-Hag A., el-Dabi M.A., el-Sadig el-Tayeb M., Khalid I.O., et al. HIV-1 and hepatitis B transmission in Sudan. AIDS 1989, 3:725-729.
9. Hyams K.C., al-Arabi M.A., al-Tagani A.A., Messiter J.F., al-Gaali A.A., George J.F. Epidemiology of hepatitis B in the Gezira region of Sudan. Am J Trop Med Hyg 1989, 40:200-206.
10. Mudawi H.M., Smith H.M., Rahoud S.A., Fletcher I.A., Babikir A.M., Saeed O.K., et al. Epidemiology of HCV infection in Gezira state of central Sudan. J Med Virol 2007, 79:383-385.
11. Mudawi H., Smith H., Fletcher I., Fedail S. Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis. J Med Virol 2007, 79:1322-1324.
12. UNAIDS. Report on the global AIDS epidemic. UNAIDS; 2010. Available at: (accessed July 2013). http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf.
13. Sulkowski M.S., Thomas D.L., Mehta S.H., Chaisson R.E., Moore R.D. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 2002, 35:182-189.
14. World Health Organization WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children 2006, WHO.
15. Barth R.E., Huijgen Q., Taljaard J., Hoepelman A.I. Hepatitis B/C and HIV in Sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 2010, 14:e1024-e1031.
16. Shimelis T., Torben W., Medhin G., Tebeje M., Andualm A., Demessie F., et al. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Sex Transm Infect 2008, 84:37-41.
17. Bwogi J., Braka F., Makumbi I., Mishra V., Bakamutumaho B., Nanyunja M., et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci 2009, 9:98-108.
18. Cunha L., Plouzeau C., Ingrand P., Gudo J.P.S., Ingrand I., Mondlane J., et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. Jo Med Virol 2007, 79:1832-1840.
19. Hoffmann C.J., Thio C.L. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007, 7:402-409.
20. Burnett R.J., Francois G., Kew M.C., Leroux-Roels G., Meheus A., Hoosen A.A., et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int 2005, 25:201-213.
21. Bodsworth N.J., Cooper D.A., Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 1991, 163:1138-1140.
22. Soriano V., Mocroft A., Peters L., Rockstroh J., Antunes F., Kirkby N., et al. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother 2010, 65:548-555.
23. Hadler S.C., Judson F.N., O'Malley P.M., Altman N.L., Penley K., Buchbinder S., et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991, 163:454-457.
24. Yousif M., Mudawi H., Bakhiet S., Glebe D., Kramvis A. Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis 2013, 13:328.
25. Oshitani H., Kasolo F., Mpabalwani M., Mizuta K., Luo N., Suzuki H., et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996, 90:235-236.
26. Matthews G.V., Ali R.J., Avihingsanon A., Amin J., Hammond R., Bowden S., et al. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals. PLoS One 2013, 8:e61297.
27. Bell T.G., Makondo E., Martinson N.A., Kramvis A., Hepatitis B. virus infection in human immunodeficiency virus infected southern African adults: occult or overt-that is the question. PLoS One 2012, 7:e45750.
28. Thio C.L. Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis 2003, 23:125-136.
29. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004, 38:S44-S48.
30. Puoti M., Torti C., Ripamonti D., Castelli F., Zaltron S., Zanini B., et al. Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome. J Acquir Immune Defic Syndr 2003, 32:259-267.
31. Hoffmann C.J., Charalambous S., Martin D.J., Innes C., Churchyard G.J., Chaisson R.E., et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008, 47:1479-1485.
32. Mphahlele M.J., Lukhwareni A., Burnett R.J., Moropeng L.M., Ngobeni J.M. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006, 35:14-20.
33. Allain J.P. Occult hepatitis B virus infection. Transfus Clin Biol 2004, 11:18-25.
34. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008, 49:652-657.
35. Melegari M., Bruno S., Wands J.R. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994, 199:292-300.
36. Attia K.A., Eholié S., Messou E., Danel C., Polneau S., Chenal H., et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol 2012, 4:218.
37. Shire N.J., Rouster S.D., Rajicic N., Sherman K.E. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004, 36:869-875.
38. Benhamou Y., Bochet M., Thibault V., Di Martino V., Caumes E., Bricaire F., et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 1999, 30:1302-1306.
39. Kim H.N., Scott J., Cent A., Cook L., Morrow R.A., Richardson B., et al. HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya. J Viral Hepat 2011, 18:e447-e452.
40. HIV/AIDS programme, World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach, 2010 revision. WHO; 2010.
41. Boyd A., Lacombe K., Miailhes P., Gozlan J., Bonnard P., Molina J.M., et al. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. J Viral Hepat 2010, 17:65-76.
42. McCarthy M.C., Burans J.P., Constantine N.T., el-Hag A.A., el-Tayeb M.E., el-Dabi M.A., et al. Hepatitis B and HIV in Sudan: a serosurvey for hepatitis B and human immunodeficiency virus antibodies among sexually active heterosexuals. Am J Trop Med Hyg 1989, 41:726-731.